Archives for March 2, 2010

← 2010

SCM lands Buccolam trial supply contract

SCM Pharma will make trial supplies of Auralis’ trail stage childhood epilepsy drug Buccolam, under a new manufacturing contract announced this week.

Stratophase & GSK work on multi-parameter monitoring

By Nick Taylor

Stratophase and GSK are part of a consortium developing a multi-parameter device capable of performing the real-time monitoring of key criteria needed to employ QbD in API production.

Watson to sell ScinoPharm share to Uni-President

By Gareth Macdonald

A significant share of contract API maker ScinoPharm Taiwan is set to change hands after Watson Pharmaceuticals decided to sell its stake to Uni-President Enterprises Corporation.

PARI launches Vios aerosol delivery system

By Staff reporter

PARI Respiratory Equipment has launched its Vios aerosol delivery system to provide a tool for quickly administering treatments to the lungs, with a small particle size and high respirable drug dose.

WuXi collaborates with J&J to bring GLP to China

By Nick Taylor

WuXi PharmaTech is collaborating with J&J Pharmaceutical R&D, providing the pharma with toxicology services and receiving training to establish GLP at its facility in Suzhou, China.

PPD opens Ireland lab; moves forward with Furiex spin-off

By Gareth Macdonald

US CRO PPD has been busy on both sides of the Atlantic, opening a clinical testing facility in Ireland and, in the US, moving forward with plans to spin-off its compound partnering business as Furiex Pharmaceuticals